All-Cause, Stroke-, and Bleed-Specific Healthcare Costs: Comparison among Patients with Non-Valvular Atrial Fibrillation (NVAF) Newly Treated with Dabigatran or Warfarin

OBJECTIVE: Our objective was to compare all-cause and stroke- and bleed-specific healthcare costs among patients with non-valvular atrial fibrillation (NVAF) treated with dabigatran or warfarin. METHODS: Administrative claims data from the MarketScan(®) Databases for 2009–2014 were used. Patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gilligan, Adrienne M., Gandhi, Pranav, Song, Xue, Wang, Cheng, Henriques, Caroline, Sander, Stephen, Smith, David M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701952/
https://www.ncbi.nlm.nih.gov/pubmed/28795348
http://dx.doi.org/10.1007/s40256-017-0244-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701952/
https://www.ncbi.nlm.nih.gov/pubmed/28795348
http://dx.doi.org/10.1007/s40256-017-0244-1

Ejemplares similares